A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity

NCT03785223 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder
Generalized Anxiety Disorder
Social Anxiety Disorder
Panic Disorder
Agoraphobia

Interventions

DRUG: Methylphenidate Hydrochloride Controlled-Release Capsules
DRUG: Placebo Capsule

Sponsor

McMaster University

Collaborators

[object Object]